US 10266825
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted A61KA61K48/005
Quick answer
US patent 10266825 (Compositions comprising alternating 2′-modified nucleosides for use in gene modulation) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K48/005